Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Inverness Medical Innovations Inc (IMA)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Inverness Medical Innovations Inc.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1145460.
Total stock buying since 2014: $1,425,270.
Total stock sales since 2014: $13,314,464.
Total stock option exercises since 2014: $12,259,067.
Table 3. Detailed insider trading at Inverness Medical Innovations Inc (IMA)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2017-08-31 | Gladwell Mark (Senior VP, Global Operations) | Option Ex | 5,000 | .00 | 0 |
| 2017-08-31 | Guerdan Melissa (SVP, Global Quality & Reg.) | Option Ex | 8,334 | .00 | 0 |
| 2017-08-31 | Cramp Daniella (Global Pres., Cardiometabolic) | Option Ex | 16,667 | 32.09 | 534,894 |
| 2017-08-31 | Malkani Sanjay (Global Pres., Toxicology) | Option Ex | 6,667 | .00 | 0 |
| 2017-08-31 | Chiniara Ellen (GC, Chief Ethics Officer&Sec) | Option Ex | 6,667 | .00 | 0 |
| 2017-08-31 | Hargadon Robert Bernard (SVP, Global Human Resources) | Option Ex | 6,667 | .00 | 0 |
| 2017-08-31 | Pelossof Avi (GlobalPres, Infectious Disease) | Option Ex | 6,667 | .00 | 0 |
| 2017-08-31 | Bridgen John (Sr VP, Business Develop) | Option Ex | 5,000 | .00 | 0 |
| 2017-06-30 | Ginsburg Geoffrey S | Option Ex | 5,530 | .00 | 0 |
| 2017-06-30 | Powers Gregg J | Option Ex | 5,530 | .00 | 0 |
| 2017-06-30 | Mckillop Thomas | Option Ex | 5,530 | .00 | 0 |
| 2017-06-30 | Roosevelt James Jr. | Option Ex | 5,530 | .00 | 0 |
| 2017-06-30 | Markison Brian A | Option Ex | 5,530 | .00 | 0 |
| 2017-06-30 | Levy John F | Option Ex | 5,530 | .00 | 0 |
| 2017-06-30 | Quelch John | Option Ex | 5,530 | .00 | 0 |
| 2017-06-30 | Goldberg Carol R | Option Ex | 5,530 | .00 | 0 |
| 2017-04-06 | Hinrichs James F. (Executive VP, CFO) | Option Ex | 16,667 | .00 | 0 |
| 2017-02-28 | Uppaluri Renuka (Senior VP, Global R&D) | Option Ex | 6,667 | .00 | 0 |
| 2017-02-16 | Uppaluri Renuka (Senior VP, Global R&D) | Option Ex | 8,163 | .00 | 0 |
| 2017-02-16 | Gladwell Mark (Senior VP, Global Operations) | Option Ex | 8,163 | .00 | 0 |
| 2017-02-16 | Guerdan Melissa (SVP, Global Quality & Reg.) | Option Ex | 9,736 | .00 | 0 |
| 2017-02-16 | Cramp Daniella (Global Pres., Cardiometabolic) | Option Ex | 9,736 | .00 | 0 |
| 2017-02-16 | Malkani Sanjay (Global Pres., Toxicology) | Option Ex | 9,736 | .00 | 0 |
| 2017-02-16 | Nawana Namal (Chief Executive Officer) | Option Ex | 47,188 | .00 | 0 |
| 2017-02-16 | Hinrichs James F. (Executive VP, CFO) | Option Ex | 13,842 | .00 | 0 |
| 2017-02-16 | Chiniara Ellen (GC, Chief Ethics Officer&Sec) | Option Ex | 9,736 | .00 | 0 |
| 2017-02-16 | Hargadon Robert Bernard (SVP, Global Human Resources) | Option Ex | 8,163 | .00 | 0 |
| 2017-02-16 | Pelossof Avi (GlobalPres, Infectious Disease) | Option Ex | 9,736 | .00 | 0 |
| 2017-02-16 | Bridgen John (Sr VP, Business Develop) | Option Ex | 8,163 | .00 | 0 |
| 2017-01-15 | Wygant Jonathan (VP, Controller, CAO) | Option Ex | 3,334 | .00 | 0 |
| 2017-01-15 | Nawana Namal (Chief Executive Officer) | Option Ex | 50,000 | .00 | 0 |
| 2016-12-30 | Pelossof Avi (GlobalPres, Infectious Disease) | Option Ex | 40,000 | 38.70 | 1,548,000 |
| 2016-10-31 | Nawana Namal (Chief Executive Officer) | Option Ex | 16,667 | .00 | 0 |
| 2016-10-14 | Chiniara Ellen (GC, Chief Ethics Officer&Sec) | Option Ex | 25,000 | 37.74 | 943,500 |
| 2016-10-03 | Gladwell Mark (Senior VP, Global Operations) | Option Ex | 1,500 | 34.40 | 51,600 |
| 2016-09-09 | Gladwell Mark (Senior VP, Global Operations) | Option Ex | 5,000 | .00 | 0 |
| 2016-09-09 | Guerdan Melissa (SVP, Global Quality & Reg.) | Option Ex | 8,333 | .00 | 0 |
| 2016-09-09 | Cramp Daniella (Global Pres., Cardiometabolic) | Option Ex | 6,667 | .00 | 0 |
| 2016-09-09 | Malkani Sanjay (Global Pres., Toxicology) | Option Ex | 6,667 | .00 | 0 |
| 2016-09-09 | Hinrichs James F. (Executive VP, CFO) | Option Ex | 16,666 | .00 | 0 |
| 2016-09-09 | Chiniara Ellen (GC, Chief Ethics Officer&Sec) | Option Ex | 6,667 | .00 | 0 |
| 2016-09-09 | Hargadon Robert Bernard (SVP, Global Human Resources) | Option Ex | 6,667 | .00 | 0 |
| 2016-09-09 | Pelossof Avi (GlobalPres, Infectious Disease) | Option Ex | 6,667 | .00 | 0 |
| 2016-09-09 | Bridgen John (Sr VP, Business Develop) | Option Ex | 5,000 | .00 | 0 |
| 2016-02-28 | Uppaluri Renuka (Senior VP, Global R&D) | Option Ex | 6,666 | .00 | 0 |
| 2016-02-01 | Guerdan Melissa (SVP, Global Quality & Reg.) | Sale | 2,500 | 54.00 | 135,000 |
| 2016-02-01 | Guerdan Melissa (SVP, Global Quality & Reg.) | Option Ex | 2,500 | 33.73 | 84,324 |
| 2015-12-30 | Nawana Namal (Chief Executive Officer) | Option Ex | 100,000 | .00 | 0 |
| 2015-11-13 | Hargadon Robert Bernard (SVP, Global Human Resources) | Buy | 1,000 | 38.99 | 38,990 |
| 2015-11-12 | Hinrichs James F. (Executive VP, CFO) | Buy | 10,000 | 39.97 | 399,700 |
| 2015-10-31 | Nawana Namal (Chief Executive Officer) | Option Ex | 16,666 | .00 | 0 |
| 2015-09-03 | Gladwell Mark (Senior VP, Global Operations) | Sale | 2,651 | 52.27 | 138,554 |
| 2015-09-03 | Guerdan Melissa (SVP, Global Quality & Reg.) | Sale | 5,135 | 52.00 | 267,020 |
| 2015-09-01 | Guerdan Melissa (SVP, Global Quality & Reg.) | Sale | 5,000 | 50.48 | 252,414 |
| 2015-09-01 | Guerdan Melissa (SVP, Global Quality & Reg.) | Option Ex | 5,000 | 18.78 | 93,900 |
| 2015-08-31 | Gladwell Mark (Senior VP, Global Operations) | Sale | 27,513 | 52.23 | 1,437,059 |
| 2015-08-31 | Gladwell Mark (Senior VP, Global Operations) | Option Ex | 32,513 | 19.63 | 638,165 |
| 2015-08-31 | Flakne Carla (VP, Chief Accounting Officer) | Option Ex | 3,333 | .00 | 0 |
| 2015-08-31 | Guerdan Melissa (SVP, Global Quality & Reg.) | Option Ex | 8,333 | .00 | 0 |
| 2015-08-31 | Cramp Daniella (Global Pres., Cardiometabolic) | Option Ex | 6,666 | .00 | 0 |
| 2015-08-31 | Malkani Sanjay (Global Pres., Toxicology) | Option Ex | 6,666 | .00 | 0 |
| 2015-08-31 | Chiniara Ellen (GC, Chief Ethics Officer&Sec) | Option Ex | 6,666 | .00 | 0 |
| 2015-08-31 | Hargadon Robert Bernard (SVP, Global Human Resources) | Option Ex | 6,666 | .00 | 0 |
| 2015-08-31 | Pelossof Avi (GlobalPres, Infectious Disease) | Option Ex | 6,666 | .00 | 0 |
| 2015-08-31 | Bridgen John (Sr VP, Business Develop) | Option Ex | 5,000 | .00 | 0 |
| 2015-08-14 | Malkani Sanjay (Global Pres., Toxicology) | Sale | 31,460 | 54.60 | 1,717,716 |
| 2015-08-14 | Malkani Sanjay (Global Pres., Toxicology) | Option Ex | 31,460 | 35.35 | 1,112,111 |
| 2015-08-07 | Hinrichs James F. (Executive VP, CFO) | Buy | 20,000 | 49.33 | 986,580 |
| 2015-06-08 | Malkani Sanjay (Global Pres., Toxicology) | Sale | 24,331 | 50.87 | 1,237,644 |
| 2015-06-08 | Malkani Sanjay (Global Pres., Toxicology) | Option Ex | 24,331 | 19.18 | 466,546 |
| 2015-06-04 | Malkani Sanjay (Global Pres., Toxicology) | Sale | 15,669 | 52.18 | 817,639 |
| 2015-06-04 | Malkani Sanjay (Global Pres., Toxicology) | Option Ex | 15,669 | 31.92 | 500,154 |
| 2015-06-01 | Bridgen John (Sr VP, Business Develop) | Sale | 7,500 | 51.19 | 383,932 |
| 2015-06-01 | Bridgen John (Sr VP, Business Develop) | Option Ex | 7,500 | 26.06 | 195,450 |
| 2015-05-29 | Bridgen John (Sr VP, Business Develop) | Sale | 22,564 | 51.16 | 1,154,487 |
| 2015-05-29 | Bridgen John (Sr VP, Business Develop) | Option Ex | 22,564 | 35.58 | 802,827 |
| 2015-05-22 | Quelch John | Option Ex | 25,000 | 28.03 | 700,750 |
| 2015-04-30 | Guerdan Melissa (SVP, Global Quality & Reg.) | Sale | 3,031 | 47.81 | 144,912 |
| 2015-04-30 | Guerdan Melissa (SVP, Global Quality & Reg.) | Option Ex | 3,031 | 25.68 | 77,836 |
| 2015-04-20 | Levy John F | Option Ex | 25,000 | 28.03 | 700,750 |
| 2015-04-06 | Guerdan Melissa (SVP, Global Quality & Reg.) | Sale | 2,500 | 50.00 | 125,000 |
| 2015-04-06 | Guerdan Melissa (SVP, Global Quality & Reg.) | Option Ex | 2,500 | 33.73 | 84,324 |
| 2015-03-23 | Guerdan Melissa (SVP, Global Quality & Reg.) | Sale | 13,476 | 48.34 | 651,497 |
| 2015-03-23 | Guerdan Melissa (SVP, Global Quality & Reg.) | Option Ex | 13,476 | 22.23 | 299,571 |
| 2015-03-17 | Bridgen John (Sr VP, Business Develop) | Sale | 25,000 | 48.53 | 1,213,250 |
| 2015-03-17 | Bridgen John (Sr VP, Business Develop) | Option Ex | 25,000 | 42.26 | 1,056,500 |
| 2015-03-16 | Flakne Carla (VP, Chief Accounting Officer) | Sale | 8,500 | 48.99 | 416,449 |
| 2015-03-16 | Flakne Carla (VP, Chief Accounting Officer) | Option Ex | 8,500 | 38.94 | 330,990 |
| 2015-02-23 | Gladwell Mark (Senior VP, Global Operations) | Sale | 13,292 | 44.64 | 593,341 |
| 2015-02-23 | Gladwell Mark (Senior VP, Global Operations) | Option Ex | 12,500 | 28.03 | 350,375 |
| 2015-01-16 | Flakne Carla (VP, Chief Accounting Officer) | Sale | 10,000 | 42.45 | 424,450 |
| 2015-01-16 | Flakne Carla (VP, Chief Accounting Officer) | Option Ex | 10,000 | 23.15 | 231,500 |
| 2014-12-30 | Nawana Namal (Chief Executive Officer) | Option Ex | 5,000 | .00 | 0 |
| 2014-12-11 | Bridgen John (Sr VP, Business Develop) | Sale | 50,000 | 37.07 | 1,853,400 |
| 2014-12-11 | Bridgen John (Sr VP, Business Develop) | Option Ex | 50,000 | 24.25 | 1,212,500 |
| 2014-08-15 | Teitel Dave (Chief Financial Officer) | Sale | 10,000 | 35.07 | 350,700 |
| 2014-08-15 | Teitel Dave (Chief Financial Officer) | Option Ex | 10,000 | 24.25 | 242,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
of IMA listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Inverness Medical Innovations Inc (symbol IMA,
CIK number 1145460) see
the Securities and Exchange Commission (SEC) website.